FDA Inspection 1091588 — Syed Jamal Mustafa, M.D.

Syed Jamal Mustafa, M.D. — FEI 3015306896

The FDA completed an inspection of Syed Jamal Mustafa, M.D. on May 31, 2019 in Bothell, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 31, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bothell, WA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance